Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation.
about
Development of a highly-potent anti-angiogenic VEGF8-109 heterodimer by directed blocking of its VEGFR-2 binding siteOpenings between defective endothelial cells explain tumor vessel leakinessThe Potential Role of Kallistatin in the Development of Abdominal Aortic AneurysmJSI-124 suppresses invasion and angiogenesis of glioblastoma cells in vitroBiology of cerebral arteriovenous malformations with a focus on inflammation.Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2Real-time changes in 1H and 31P NMR spectra of malignant human mammary epithelial cells during treatment with the anti-inflammatory agent indomethacin.Biomarkers and Microscopic Colitis: An Unmet Need in Clinical Practice.Factors promoting tumor angiogenesis.PRH/Hhex controls cell survival through coordinate transcriptional regulation of vascular endothelial growth factor signaling.Strategies for vascularization of polymer scaffoldsThe danger model approach to the pathogenesis of the rheumatic diseases.Confocal laser endomicroscopy: a new gold standard for the assessment of mucosal healing in ulcerative colitis.Target therapy using a small molecule inhibitor against angiogenic receptors in pancreatic cancer.Novel therapies for recurrent ovarian cancer management.SNS-032 prevents tumor cell-induced angiogenesis by inhibiting vascular endothelial growth factorNovel 14S,21-dihydroxy-docosahexaenoic acid rescues wound healing and associated angiogenesis impaired by acute ethanol intoxication/exposure.Plasma VEGF-related polymorphisms are implied in autoimmune thyroid diseases.Pro- and anti-angiogenic VEGF mRNAs in autoimmune thyroid diseases.C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer.Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGFA systems approach to hemostasis: 4. How hemostatic thrombi limit the loss of plasma-borne molecules from the microvasculature.Autonomously vascularized cellular constructs in tissue engineering: opening a new perspective for biomedical scienceAP-1 transcription factor mediates VEGF-induced endothelial cell migration and proliferation.In vivo imaging of extraction fraction of low molecular weight MR contrast agents and perfusion rate in rodent tumors.Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesisActivation of the epidermal growth factor receptor promotes lymphangiogenesis in the skin.Antiangiogenics and radiotherapy.Target effector role of vascular endothelium in the inflammatory response: insights from the clinical trial of anti-TNF alpha antibody in rheumatoid arthritisThe Poly-cistronic miR-23-27-24 Complexes Target Endothelial Cell Junctions: Differential Functional and Molecular Effects of miR-23a and miR-23b.HIV-1 Tat mimetic of VEGF correlates with increased microvessels density in AIDS-related diffuse large B-cell and Burkitt lymphomas.The antiangiogenic agent ZD4190 prevents tumour outgrowth in a model of minimal residual carcinoma in deep tissuesSerum vascular endothelial growth factor in pediatric patients with community-acquired pneumonia and pleural effusion.Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation.Real-time analysis of the kinetics of angiogenesis and vascular permeability in an animal model of wound healingCan O2 dysregulation induce premature aging?Current thoughts on angiogenesis.Timing of administration of bevacizumab chemotherapy affects wound healing after chest wall port placement.Brewing complications: the effect of acute ethanol exposure on wound healing
P2860
Q24302190-11670DDA-F3FB-4DC9-966D-64BB94FD211AQ24681507-E78A5107-5C48-47FB-B80E-C8B40676D20BQ26741231-28651A5B-6B13-4091-A45C-1D6D074D9B3DQ28544728-6F1C5C82-D7F8-4AE6-B058-CD7889F9C8B2Q30301287-A5C0D634-9FE2-4966-8937-F2F98F41F027Q30438929-1BA54477-797D-45B0-A8B7-75DE644DDA17Q30744878-7309AE44-4D2A-47DB-B42C-DD36830BBCEBQ33653647-E69C2156-4BEE-4977-B7EE-35E393661678Q33791689-25F83DFD-D0D7-49B1-8CDE-21AFB38D6705Q33826204-50774244-4173-4036-BB83-618D9583581FQ34196960-4CC80540-3767-4070-BA6A-179B01B25A22Q35564107-7742D311-A349-439F-9889-A2405A910C21Q35591302-914B3D27-D2EB-4FC1-AFFD-07E973CB8191Q35668675-BD7F6869-8524-4B44-9F64-01C8AA35F844Q35782940-4DF91CBD-5E02-48CF-A3E2-5EAD3BE3B886Q35812724-478458EA-AD6F-48E9-88D9-3E843105D5CBQ35841779-00CD1E93-99D2-494A-BCC5-EE9012B4039BQ35949808-6369FDD9-CDDA-47BC-8EBD-26D0ACA411F1Q36095767-CDB865C1-A029-4078-ABB6-E08522644A10Q36308275-DA7883C1-3E6A-4237-82F0-6686DAE80F0FQ36413901-11033801-79CF-422E-828D-20B200D12F90Q36623011-FD7AEA6C-D630-4CAF-9B8B-508FB7DF7F39Q36727877-87B9EA0F-1810-4A04-AC61-098F542CAA71Q36762615-AED38C5F-EA6A-4D56-8607-01099CD5193EQ36813128-B5A92512-977A-4AB1-9E2B-D281BD69D9B5Q36876253-7491AD7A-2FF3-43B9-A4C9-FDA6FFA6F564Q36882284-C26771DE-AEFF-49EF-A6BF-DFFE2EF0D36FQ37100821-AB1BFB98-8121-4150-B48C-DE53A4A0E037Q37222791-ACB91AA9-95C2-42DC-8A20-6B71544566BFQ37229283-ACF71A0F-D50F-4522-A783-46C43FDBD72DQ37256210-2EDA160E-FEEF-46F8-99C4-A8CB2C49534BQ37266075-0E4138F9-634E-4C1D-8498-D51B8C1FD23CQ37287554-C8E7A7E0-186B-4A4C-93E4-E306ADD3FA28Q37313133-BA78F5A5-37EE-4D03-A2B3-234625003CF7Q37319826-1976F412-B347-48F8-8786-6784CBA3160EQ37336269-CE004559-D4AF-4112-AB80-9B67E9A377F4Q37346880-E8610A40-7452-4EDD-B98A-4F0BE1699E6FQ37365156-B837FC7E-30C2-47A6-B179-E6B7877AF908Q37406167-C4AAC95E-50D9-41B3-8357-CDEEED909BD2Q37415500-BC54A04D-27C0-4304-B179-7693AE6D8924
P2860
Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Vascular permeability factor/v ...... n malignancy and inflammation.
@en
type
label
Vascular permeability factor/v ...... n malignancy and inflammation.
@en
prefLabel
Vascular permeability factor/v ...... n malignancy and inflammation.
@en
P2093
P356
P1476
Vascular permeability factor/v ...... n malignancy and inflammation.
@en
P2093
P304
P356
10.1159/000236988
P577
1995-05-01T00:00:00Z